US equities |
INTC $64.14 ▼-30.34% NVDA $202.99 ▼-5.00% MU $870.59 ▼-6.82% AMZN $239.72 ▼-1.67% SNDK $1,137.07 ▼-14.51% AMD $497.99 ▼-12.08% AAPL $344.03 ▼-1.40% GOOGL $278.77 ▼-1.78%
FinancialContent

Bausch Health Companies Inc. Common Stock (NY:BHC)

8.210 -0.700 (-7.86%)
Delayed Quote Updated: 3:42 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Via ACCESS Newswire
News headline image
Bausch Health Announces First Quarter 2025 Results
Via ACCESS Newswire
News headline image
Earnings Scheduled For April 30, 2025 ↗
 
Via Benzinga
News headline image
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
Via ACCESS Newswire
News headline image
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)
Via ACCESS Newswire
News headline image
Bausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding Shares ↗
This disclosure comes days after the company announced a new “poison pill” plan to safeguard shareholders’ rights and prevent hostile takeovers. 
Via Stocktwits
News headline image
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
Via ACCESS Newswire
News headline image
Earnings Scheduled For February 19, 2025 ↗
 
Via Benzinga
News headline image
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
Via ACCESS Newswire
News headline image
Bausch Health Announces Filing of Supplement to Proxy Statement
Via ACCESS Newswire
News headline image
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
Via ACCESS Newswire
News headline image
Bausch Health Announces Adoption of Shareholder Rights Plan
Via ACCESS Newswire
News headline image
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Via ACCESS Newswire
News headline image
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Via ACCESS Newswire
News headline image
Bausch Health to Announce First Quarter Results on April 30
Via ACCESS Newswire
News headline image
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
Via ACCESS Newswire
News headline image
Bausch Health Announces Conditional Redemption of Senior Notes
Via ACCESS Newswire
News headline image
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities
Via ACCESS Newswire
News headline image
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
Via ACCESS Newswire
News headline image
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
Via ACCESS Newswire
News headline image
Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises ↗
The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China. 
Via Stocktwits
Topics Earnings
News headline image
Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance ↗
Bausch Health Companies reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report: 
Via Benzinga
News headline image
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Via ACCESS Newswire
News headline image
Bausch Health Provides Update on Strategic Alternatives
Via ACCESS Newswire
News headline image
Tesla, Nvidia, GM And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
Via ACCESS Newswire
News headline image
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >